Clinical Trial Detail

NCT ID NCT04098081
Title 1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Maryland, Baltimore
Indications

pancreatic adenocarcinoma

Therapies

Galeterone + Gemcitabine

Galeterone

Age Groups: adult senior

No variant requirements are available.